Key Features
* Unique perspectives on advancements in the diagnosis and treatment of tumors of the nervous system
* An in-depth exploration of new strategies, including diagnostics, and gene and molecularly targeted therapies
* A state-of-the-art reference that summarizes the clinical features and management of the many neurological manifestations of tumors of the nervous system
Description
This volume provides unique insights into the field of neuro-oncology by presenting new advancements and research in the study and treatment of tumors of the nervous system, their progression, side effects, and the adverse effects of some therapies. An in-depth exploration of the management of tumors and new therapeutic strategies is extensively covered, including groundbreaking research on gene therapy and molecularly targeted treatments.
Clinicians will gain a better understanding of the many neurological manifestations of tumors through a thorough analysis of recent developments in the field, including new diagnostic imaging techniques. In addition, fresh attention to molecular biology, immunology, and other clinical aspects of these types of tumors is presented.
Neuro-Oncology, Part II, 1st Edition
SECTION 4 Specific tumor types
29. Low-grade gliomas
30. Anaplastic astrocytomas
31. Anaplastic oligodendroglial tumors
32. Glioblastoma
33. Gliomatosis cerebri
34. Primary central nervous system lymphoma
35. Medulloblastoma and primitive neuroectodermal tumors
SECTION 5 Rare brain tumors
36. Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic
neuroepithelial tumors, pleiomorphic xanthoastrocytomas, and pilocytic
astrocytomas
)
37. Neurofibromatosis and other genetic syndromes
SECTION 6 Tumors at special sites
38. Brainstem tumors
39. Optic, hypothalamic and thalamic tumours
40. Pineal parenchymal tumours, embryonal tumours and germ cell tumours
41. Tumors of the cerebellopontine angle
42. Tumors of the meninges)
43. The management of skull base tumors
44. Peripheral nerve tumors
SECTION 7 Neurologic complications of systemic cancer
45. General oncology and neurologic complications
46. Neurologic complications of solid tumors
47. Neurologic complications of leukaemia and lymphoma
48. Neurologic complications in plasma cell dyscrasias
49. Brain metastases
50. Neoplastic meningitis
51. Spinal cord involvement
52. Neuromuscular complications
53. Neurovascular complications of solid tumors and hematological neoplasms
54. Infectious, metabolic, and endocrine complications
55. Central nervous system paraneoplastic disease
56. Paraneoplastic disorders of the peripheral nervous system
SECTION 8 Complications from treatments
57. Complications of chemotherapy in Neuro-oncology
58. Complications of radiotherapy to the central nervous system
59. Neurological complications of chemotherapy to the central nervous system
60. Neurological complications of chemotherapy to the peripheral nervous system
61. General and neurological complications of targeted therapy
